Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

15.26
Delayed Data
As of Jul 29
 -0.46 / -2.93%
Today’s Change
7.85
Today|||52-Week Range
16.83
+25.49%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close15.72
Today’s open15.63
Day’s range-- - --
Volume705,871
Average volume (3 months)914,395
Market cap$1.1B
Dividend yield--
Data as of 07/29/2015

Growth & Valuation

Earnings growth (last year)-23.64%
Earnings growth (this year)-50.74%
Earnings growth (next 5 years)-22.83%
Revenue growth (last year)-21.48%
P/E ratioNM
Price/Sales59.67
Price/Book14.96

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc-1.02-3.09%
ADAPAdaptimmune Therapeu...+0.96+6.27%
FMIFoundation Medicine ...-0.72-2.40%
CHRSCoherus Biosciences ...-0.70-1.94%
Data as of 07/29/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$13.6M
Annual profit (last year)-$45.2M
Net profit margin-332.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Chief Financial Officer, Treasurer, CAO &
SVP
Thomas R. Staab
Corporate headquarters
Birmingham, Alabama

Forecasts